Connect with us

Business

Is the Spotlight Heating Up for Canopy Growth Corp (NYSE:CGC)?

Published

on

As we see it, Canopy Growth Corp (NYSE:CGC) would make a great pair trade if paired with a short position in TLRY. The stock is perhaps rich, but hardly as rich as TLRY. It is also quite well-positioned in terms of a diversified strategic investment portfolio – probably second best on the planet in that respect to Aurora. Now, Canopy has set another first in place.

To wit: The company just announced it has completed a legal transfer of cannabis products to a research partner in the United States. According to the release, “To the Company’s knowledge, this transfer is the first export of legal cannabis products from Canada to the United States pursuant to an import permit issued by the federal United States Drug Enforcement Administration (DEA). The shipment was completed for the sole purpose of supporting medical research and development.”

Canopy Growth Corp (NYSE:CGC) engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.

The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

In the company’s words, Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

The Company has operations in 12 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector.

 

To Boldly Go

Canopy Growth Corp (NYSE:CGC) generated sales of $25.9M, according to information released in the company’s most recent quarterly financial report.

That adds up to a sequential quarter-over-quarter growth rate of 13.6% on the top line.

We know this is an extremely intensive business in terms of cash from operations, which makes it unsurprising that the company has a strong balance sheet, with cash and marketable securities ($659.8M) far exceeding current obligations of $130.6M.

As we discussed in our introductory section, CGC just announced it has completed a legal transfer of cannabis products to a research partner in the United States. In terms of the action, shares of the stock have powered higher over the past week, rallying roughly 7% in that time on strong overall action.

And those gains have come on surging volume, with interest rising nearly 200% relative to its longer-term transaction volume averages. In other words, the spotlight is heating up in front of Canadian adult-use legalization.

“The United States presents a unique market opportunity and as the most established cannabis business in the world we, in turn, offer a unique ability to advance standardization, IP development, and clinical research that can improve the understanding and legal application of cannabis and cannabinoids,” said Mark Zekulin, President and Co-CEO, Canopy Growth. “By engaging in the market through federally legal means and with the right partners, we can create a US-based centre of expertise while also supporting our rapidly expanding global business.”

Moreover, it’s not surprising to see Canopy finding an advantaged market position once again.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade




FEATURED STORIES

INDUSTRIAL HEMP5 days ago

Cronos Group Inc. (NASDAQ:CRON) Pops On Altria Acquisition Talk After Q3 Net Loss Disappointment

Cronos Group Inc. (NASDAQ:CRON) is skyrocketing up the charts having emerged it is an acquisition target of Marlboro cigarette-maker Altria...

Business5 days ago

American Green Inc (OTCMKTS:ERBB) Kicks Off December On Rough Patch

American Green Inc (OTCMKTS:ERBB) seems to have started the month of December on a rather dull pace after closing the...

Business7 days ago

HempAmericana Inc. (OTCMKTS:HMPQ) Due For A Bounce Back As Sentiments Turn Bullish

HempAmericana Inc. (OTCMKTS: HMPQ) might as well have served groundbreaking catalysts set to trigger a rally from the current lows....

Business7 days ago

Hemp Inc. (OTCMKTS:HEMP) Surging On Massive Opportunity In Hemp Sector

Hemp Inc. (OTCMKTS:HEMP) bounce back after a steep pullback is gaining momentum. The stock could as well break out of...

Business1 week ago

Why Medmen Enterprises Inc (OTCMKTS:MMNFF) Could be Set to Rip

Medmen Enterprises Inc (OTCMKTS:MMNFF) has been beaten down soundly over the past 6 weeks. The stock continues to set up...

Business2 weeks ago

Can Green Thumb Industries Inc (OTCMKTS:GTBIF) Get Some Traction Following Primary Data?

Green Thumb Industries Inc (OTCMKTS:GTBIF) is another cannabis player to hit the wires with its quarterly financials. This comes at...

Business2 weeks ago

Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) Hits the Wires with Q Data as Farm Bill Readies

Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) just announced financial results for the third quarter and nine months ended September 30, 2018....

Business2 weeks ago

KushCo Holdings Inc (OTCMKTS:KSHB) Beats Single Analyst Estimates on Q3 Numbers

KushCo Holdings Inc (OTCMKTS:KSHB) just announced financial results for its fiscal year 2018, for the period ended August 31, 2018....

Business2 weeks ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Looks to Solidify Support on Expanding Supplier Status

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has been an interesting outperformer in the cannabis space for most of the year. However, shares...

Business3 weeks ago

Growlife Inc (OTCMKTS:PHOT) Could be Flying Under the Radar

Growlife Inc (OTCMKTS:PHOT) has been grinding lower over the past 10 months, which represents some clear underperformance relative to the...

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play